12:00 AM
 | 
Apr 24, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Extra formulation technology regulatory update

SUPG received U.S. Patent No. 6,048,845 covering the company's Extra technology, which the company said...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >